Achieve Life Sciences, Inc. Operating Lease, Payments
Achieve Life Sciences, Inc. (ACHV) reported Operating Lease, Payments of $15.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2026-08-11
- Achieve Life Sciences, Inc. operating lease, payments for the quarter ending 2026-06-30 was $15.00K, a 15.38% increase year-over-year.
- Achieve Life Sciences, Inc. operating lease, payments for the quarter ending 2026-03-31 was $15.00K, a 15.38% increase year-over-year.
- Achieve Life Sciences, Inc. operating lease, payments for the quarter ending 2025-12-31 was $15.00K, a 25.00% increase year-over-year.
- Achieve Life Sciences, Inc. operating lease, payments for the quarter ending 2025-09-30 was $14.00K, a 12.50% decline year-over-year.
- Achieve Life Sciences, Inc. operating lease, payments for fiscal 2025 was $114.00K, a 93.22% increase from fiscal 2024.
- Achieve Life Sciences, Inc. operating lease, payments for fiscal 2024 was $59.00K, a 3.51% increase from fiscal 2023.
- Achieve Life Sciences, Inc. operating lease, payments for fiscal 2023 was $57.00K, a 3.39% decline from fiscal 2022.
- Achieve Life Sciences, Inc. operating lease, payments for fiscal 2022 was $59.00K, a 28.92% decline from fiscal 2021.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month |
|---|---|---|---|---|
| 2026-06-30 | $15.00K 10-Q · filed 2026-08-11 | $30.00K 10-Q · filed 2026-08-11 | $45.00K derived: sum of 3 quarters · filed 2026-08-11 | $59.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | $15.00K 10-Q · filed 2026-05-12 | $30.00K derived: sum of 2 quarters · filed 2026-05-12 | $44.00K derived: sum of 3 quarters · filed 2026-05-12 | $57.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | $15.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $29.00K derived: sum of 2 quarters · filed 2026-03-24 | $42.00K derived: sum of 3 quarters · filed 2026-08-11 | $114.00K 10-K · filed 2026-03-24 |
| 2025-09-30 | $14.00K 10-Q · filed 2025-11-06 | $27.00K derived: sum of 2 quarters · filed 2026-08-11 | $99.00K 10-Q · filed 2025-11-06 | $52.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | $13.00K 10-Q · filed 2026-08-11 | $85.00K 10-Q · filed 2026-08-11 | $38.00K derived: sum of 3 quarters · filed 2026-08-11 | $54.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | $13.00K 10-Q · filed 2026-05-12 | $25.00K derived: sum of 2 quarters · filed 2026-05-12 | $41.00K derived: sum of 3 quarters · filed 2026-05-12 | $56.00K derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $28.00K derived: sum of 2 quarters · filed 2026-03-24 | $43.00K derived: sum of 3 quarters · filed 2026-03-24 | $59.00K 10-K · filed 2026-03-24 |
| 2024-09-30 | $16.00K 10-Q · filed 2025-11-06 | $31.00K derived: sum of 2 quarters · filed 2025-11-06 | $47.00K 10-Q · filed 2025-11-06 | $61.00K derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $15.00K 10-Q · filed 2025-08-07 | $31.00K 10-Q · filed 2025-08-07 | $45.00K derived: sum of 3 quarters · filed 2025-08-07 | $60.00K derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $16.00K 10-Q · filed 2025-05-13 | $30.00K derived: sum of 2 quarters · filed 2025-05-13 | $45.00K derived: sum of 3 quarters · filed 2025-05-13 | $58.00K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $29.00K derived: sum of 2 quarters · filed 2025-03-11 | $42.00K derived: sum of 3 quarters · filed 2025-03-11 | $57.00K 10-K · filed 2025-03-11 |
| 2023-09-30 | $15.00K 10-Q · filed 2024-11-07 | $28.00K derived: sum of 2 quarters · filed 2024-11-07 | $43.00K 10-Q · filed 2024-11-07 | $57.00K derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $13.00K 10-Q · filed 2024-08-13 | $28.00K 10-Q · filed 2024-08-13 | $42.00K derived: sum of 3 quarters · filed 2024-08-13 | $58.00K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $15.00K 10-Q · filed 2024-05-09 | $29.00K derived: sum of 2 quarters · filed 2024-05-09 | $45.00K derived: sum of 3 quarters · filed 2024-05-09 | $61.00K derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $30.00K derived: sum of 2 quarters · filed 2024-03-28 | $46.00K derived: sum of 3 quarters · filed 2024-03-28 | $59.00K 10-K · filed 2024-03-28 |
| 2022-09-30 | $16.00K 10-Q · filed 2023-11-09 | $32.00K derived: sum of 2 quarters · filed 2023-11-09 | $45.00K 10-Q · filed 2023-11-09 | $60.00K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $16.00K 10-Q · filed 2023-08-14 | $29.00K 10-Q · filed 2023-08-14 | $44.00K derived: sum of 3 quarters · filed 2023-08-14 | $59.00K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $13.00K 10-Q · filed 2023-05-09 | $28.00K derived: sum of 2 quarters · filed 2023-05-09 | $43.00K derived: sum of 3 quarters · filed 2023-05-09 | $58.00K derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $15.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $30.00K derived: sum of 2 quarters · filed 2023-03-16 | $45.00K derived: sum of 3 quarters · filed 2023-03-16 | $83.00K 10-K · filed 2023-03-16 |
| 2021-09-30 | $15.00K 10-Q · filed 2022-11-14 | $30.00K derived: sum of 2 quarters · filed 2022-11-14 | $68.00K 10-Q · filed 2022-11-14 | $117.00K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $15.00K 10-Q · filed 2022-08-11 | $53.00K 10-Q · filed 2022-08-11 | $102.00K derived: sum of 3 quarters · filed 2022-08-11 | $149.00K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $38.00K 10-Q · filed 2022-05-12 | $87.00K derived: sum of 2 quarters · filed 2022-05-12 | $134.00K derived: sum of 3 quarters · filed 2022-05-12 | $180.00K derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $49.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $96.00K derived: sum of 2 quarters · filed 2022-03-10 | $142.00K derived: sum of 3 quarters · filed 2022-03-10 | $186.00K 10-K · filed 2022-03-10 |
| 2020-09-30 | $47.00K 10-Q · filed 2021-11-09 | $93.00K derived: sum of 2 quarters · filed 2021-11-09 | $137.00K 10-Q · filed 2021-11-09 | $180.00K derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $46.00K 10-Q · filed 2021-08-12 | $90.00K 10-Q · filed 2021-08-12 | $133.00K derived: sum of 3 quarters · filed 2021-08-12 | $175.00K derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $44.00K 10-Q · filed 2021-05-13 | $87.00K derived: sum of 2 quarters · filed 2021-05-13 | $129.00K derived: sum of 3 quarters · filed 2021-05-13 | $170.00K derived: sum of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | $43.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $85.00K derived: sum of 2 quarters · filed 2021-03-11 | $126.00K derived: sum of 3 quarters · filed 2021-03-11 | $176.00K 10-K · filed 2021-03-11 |
| 2019-09-30 | $42.00K 10-Q · filed 2020-11-12 | $83.00K derived: sum of 2 quarters · filed 2020-11-12 | $133.00K 10-Q · filed 2020-11-12 | |
| 2019-06-30 | $41.00K 10-Q · filed 2020-08-06 | $91.00K 10-Q · filed 2020-08-06 | ||
| 2019-03-31 | $50.00K 10-Q · filed 2020-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |